3 documents found, page 1 of 1
Association between bile acid metabolism and bone mineral density in postmenopa...
Zhao, Yu-Xiao; Song, Yu-Wen; Zhang, Liang; Zheng, Feng-Jie; Wang, Xue-Meng; Zhuang, Xiang-Hua; Wu, Fei; Liu, JianOBJECTIVES: Previous studies have not shown any correlation between bile acid metabolism and bone mineral density (BMD) in women with postmenopausal osteoporosis. Thus, the current study evaluated the association between bile acid levels as well as BMD and bone turnover marker levels in this group of women. METHODS: This single-center cross-sectional study included 150 postmenopausal Chinese women. According to...
Vapor–solid synthesis of monolithic single-crystalline CoP nanowire electrodes ...
Li, Wei; Gao, Xuefei; Xiong, Dehua; Xia, Fang; Liu, Jian; Song, Wei-Guo; Xu, Junyuan; Thalluri, Sitaramanjaneya Mouli; Cerqueira, M. F.; Fu, XiuliElectrochemical water splitting into hydrogen and oxygen is a promising technology for sustainable energy storage. The development of earth-abundant transition metal phosphides (TMPs) to catalyze the hydrogen evolution reaction (HER) and TMP-derived oxy-hydroxides to catalyze the oxygen evolution reaction (OER) has recently drawn considerable attention. However, most monolithically integrated metal phosphide el...
Synergistic growth inhibition by sorafenib and vitamin K2 in human hepatocellul...
Zhang, Yafei; Zhang, Bicheng; Zhang, Anran; Zhao, Yong; Zhao, Jie; Liu, Jian; Gao, Jianfei; Fang, Dianchun; Rao, ZhiguoOBJECTIVE: Sorafenib is an oral multikinase inhibitor that has been proven effective as a single-agent therapy in hepatocellular carcinoma, and there is a strong rationale for investigating its use in combination with other agents. Vitamin K2 is nearly non-toxic to humans and has been shown to inhibit the growth of hepatocellular carcinoma. In this study, we evaluated the effects of a combination of sorafenib a...